AI in drug development is a vague term that might mean many things, and today, Owkin is announcing it has enrolled the first patient in a phase 1 study of OKN4395, its “AI-optimized” candidate for ...
A reason 2025 could be a big year for Health Catalyst is ... from the rise of precision medicine and AI in health care. Its over 20 petabytes of data create a moat that will be difficult for ...
We recently compiled a list of the 12 Best Big Name Stocks to Invest in Now. In this article, we are going to take a look at where UnitedHealth Group Incorporated (NYSE:UNH) stands against other best ...
January 29, 2025 • Robert F. Kennedy Jr. faced senators today in a contentious confirmation hearing to serve as Health and Human Services Secretary under President Trump. He's a former Democrat ...
Greek authorities said Friday they dismantled a criminal network accused of exploiting migrant health care identification numbers to illegally distribute psychiatric ...
Health-care companies rose after more promising data for the best-selling Glucagon-like Peptide inhibitor drugs. Shares of Novo Nordisk and Eli Lilly, the two leading producers of GLP-1 drugs ...